MeSH term | MeSH ID | Detail |
---|---|---|
Pancreatic Neoplasms | D010190 | 77 associated lipids |
Body Weight | D001835 | 333 associated lipids |
Arteriosclerosis | D001161 | 86 associated lipids |
Norethindrone is a lipid of Sterol Lipids (ST) class. Norethindrone is associated with abnormalities such as Endometriosis, site unspecified, Wiskott-Aldrich Syndrome and Estrogenic effect. The involved functions are known as Hemorrhage, Phosphorylation, Apoptosis, DNA Repair and Cell Cycle. Norethindrone often locates in Blood, Back, Body tissue, Nucleolar and Human tissue. The associated genes with Norethindrone are MMP gene, NR3C1 gene and Genes, Reporter. The related lipids are Steroids, 4,17 beta-dihydroxy-4-androstene-3-one, 4-estren-3,17-diol and Estranes.
To understand associated biological information of Norethindrone, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
Norethindrone is suspected in Endometriosis, site unspecified, Estrogenic effect and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with Norethindrone
MeSH term | MeSH ID | Detail |
---|---|---|
Pancreatic Neoplasms | D010190 | 77 associated lipids |
Body Weight | D001835 | 333 associated lipids |
Arteriosclerosis | D001161 | 86 associated lipids |
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
There are no associated biomedical information in the current reference collection.
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Koch P | Allergic contact dermatitis from estradiol and norethisterone acetate in a transdermal hormonal patch. | 2001 | Contact Derm. | pmid:11205390 |
Bhathena RK | The long-acting progestogen-only contraceptive injections: an update. | 2001 | BJOG | pmid:11213001 |
Wu Z et al. | Simultaneous quantitative determination of norgestrel and progesterone in human serum by high-performance liquid chromatography-tandem mass spectrometry with atmospheric pressure chemical ionization. | 2000 | Analyst | pmid:11219053 |
Saltevo J et al. | Plasma endothelin in postmenopausal women with type 2 diabetes mellitus and metabolic syndrome: a comparison of oral combined and transdermal oestrogen-only replacement therapy. | 2000 | Diabetes Obes Metab | pmid:11225744 |
Rockson SG et al. | Plasma dopamine-beta-hydroxylase activity in oral contraceptive hypertension. | 1975 | Circulation | pmid:1122595 |
Rozenberg S et al. | Constant estrogen, intermittent progestogen vs. continuous combined hormone replacement therapy: tolerability and effect on vasomotor symptoms. | 2001 | Int J Gynaecol Obstet | pmid:11226444 |
Slick GL et al. | Hypertension, renal vein thrombosis and renal failure (occurring in a patient on an oral contraceptive agent). | 1975 | Clin. Nephrol. | pmid:1122661 |
Weiner E and Johansson ED | Plasma levels of norethindrone after i.m. injection of 200 mg norethindrone enanthate. | 1975 | Contraception | pmid:1122756 |
Kamischke A et al. | Intramuscular testosterone undecanoate and norethisterone enanthate in a clinical trial for male contraception. | 2001 | J. Clin. Endocrinol. Metab. | pmid:11232016 |
Aisaka K | [Add back therapy for patients with endometriosis]. | 2001 | Nippon Rinsho | pmid:11235150 |